1. Williams P, Berkley J. Dysentery (Shigellosis) Current WHO Guidelines and The WHO Essential Medicine List for Children. 2016. https://www.who.int/selection_medicines/committees/expert/21/applications/s6_paed_antibiotics_appendix5_dysentery.pdf
2. Meiyanti M, Salim O, et al. Antibiotic susceptibility of Salmonella, Shigella and Vibrio isolated from diarrhea patients in Jakarta, Indonesia. Jurnal Kedokteran dan Kesehatan Indonesia, 2016. 7(3), pp.95-101.
3. WHO. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization. 2014. http://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=80B0BC475FF317B963716656BE00A1A9?sequence=1
4. Abbasi E, Abtahi H, et al. Multidrug-resistant Shigella infection in pediatric patients with diarrhea from central Iran. Infect Drug Resist. 2019 Jun 7;12:1535-1544.
5. Williams PCM, Berkley JA. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 2018 Nov;38(sup1):S50-S65.
6. Das SK, Klontz EH, et al. Characteristics of Multidrug Resistant Shigella and Vibrio cholerae O1 Infections in Patients Treated at an Urban and a Rural Hospital in Bangladesh. ISRN Microbiol. 2013 Dec 22;2013:213915.
7. Ranjbar R, Farahani A. Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment. Infect Drug Resist. 2019;12:3137-3167.
8. Lefèvre S, Njamkepo E,. Rapid emergence of extensively drug-resistant Shigella sonnei in France. Nat Commun. 2023 Jan 28;14(1):462.
9. Baharvand A, Molaeipour L, et al. The increasing antimicrobial resistance of Shigella species among Iranian pediatrics: a systematic review and meta-analysis. Pathog Glob Health. 2023 Oct;117(7):611-622.
10. Zakharian G, Sukrama D, et al. Pemberian antibiotik cefotaxime dengan konsentrasi sublethal pada isolat Klebsiella pneumoniae yang resisten terhadap ampicilin menginduksi Multi Drug Resisten (MDR). Intisari Sains Medis, 2018. Volume 9, Number 1: 64-70
11. Dhital S, Sherchand JB, et al. Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production. BMC Res Notes. 2017 Jun 5;10(1):192.
12. Kim JS, Kim JJ, et al. Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, Republic of Korea. Emerg Infect Dis. 2015 Jul;21(7):1247-50.
13. CDC. Update – CDC Recommendations for Managing and Reporting Shigella Infections with Possible Reduced Susceptibility to Ciprofloxacin. 2018. https://emergency.cdc.gov/han/han00411.asp
14. Mannion AJ, Martin HR, et al. Plasmid-Mediated Quinolone Resistance in Shigella flexneri Isolated From Macaques. Front Microbiol. 2018 Mar 5;9:311.
15. Tjaniadi P, Lesmana M, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg. 2003 Jun;68(6):666-70. PMID: 12887025.
16. Poramathikul K, Bodhidatta L, et al. Multidrug-Resistant Shigella Infections in Patients with Diarrhea, Cambodia, 2014-2015. Emerg Infect Dis. 2016;22(9):1640-1643.
17. Darton TC, Tuyen HT, et al. Azithromycin Resistance in Shigella spp. in Southeast Asia. Antimicrob Agents Chemother. 2018;62(4):e01748-17. Published 2018 Mar 27.
18. Kim YJ, Park KH, et al. Guideline for the Antibiotic Use in Acute Gastroenteritis. Infect Chemother. 2019;51(2):217-243.